Liothyronine
Indication
Add-on treatment for refractory hypothyroidism despite adequate replacement with levothyroxine – new patients.
Amber level 0
Brand:
Tertroxin®
Nice TA:
Commissioning responsibility:
CCG
PbR excluded:
No
BNF chapter:
Endocrine system
Background
*Amber 0 – following successful 3 month trial (to be conducted in secondary care)*
Please note: all other potential causes of symptoms must be excluded. Patients are eligible for a three month trial initially with the option to continue if there is clinical benefit. Patients with a supressed TSH should be referred for a secondary care opinion before continuing liothyronine in primary care
Recommendation
LSCMMG Recommendation:
Amber level 0
Reason for decision:
Suitable for GP prescribing following recommendation/initiation by specialist
Supporting documents: